NCT03035747

Brief Summary

Ongoing registration of patients with varicose veins disease treated by means of conventional surgery, endovenous thermal ablations, sclerotherapy, non-tumescent non-thermal methods

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
124mo left

Started Jul 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Jul 2016Jul 2036

Study Start

First participant enrolled

July 1, 2016

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 25, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 30, 2017

Completed
19.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2036

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2036

Last Updated

March 13, 2024

Status Verified

March 1, 2024

Enrollment Period

20 years

First QC Date

January 25, 2017

Last Update Submit

March 11, 2024

Conditions

Keywords

registryvaricose veinsconventional surgerythermal ablationradiofrequencylasersclerotherapy

Outcome Measures

Primary Outcomes (1)

  • Change in patency target veins assessed by duplex ultrasonography in different follow up periods after conventional surgery, endovenous thermal ablations, sclerotherapy or non-tumescent non-thermal methods

    Baseline, 3 - 6, 12 months post-intervention

Secondary Outcomes (3)

  • Change in Quality of Life (QoL), assessed by Short form (SF)-36 health survey (optional)

    Baseline, 3 and 12 months post-intervention

  • Change in Venous Clinical Severity Score (VCSS) (optional)

    Baseline, 3 and 12 months post-intervention

  • Change in Quality of Life (QoL), assessed by Aberdeen Varicose Vein Questionnaire (AVVQ) (optional)

    Baseline, 3 and 12 months post-intervention

Interventions

high ligation and stripping of incompetent saphenous veins

endovenous laser ablation of incompetent saphenous veins

sclerotherapyPROCEDURE

ultrasound guided or catheter or or any other methods sclerotherapy of incompetent saphenous or varicose veins

endovenous radiofrequency ablation of incompetent saphenous veins

phlebectomyPROCEDURE

hooks phlebectomy of varicose veins

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing interventions in cases varicose vein disease

You may qualify if:

  • Varicose veins with any source of pathological reflux, C2 - C6 according to the CEAP classification

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medalp private surgery clinic

Saint Petersburg, 197758, Russia

RECRUITING

Related Links

MeSH Terms

Conditions

Varicose Veins

Interventions

Sclerotherapy

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Drug TherapyTherapeutics

Central Study Contacts

Evgeny Ilyukhin, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Сhief surgeon Medalp Private Surgery Clinic

Study Record Dates

First Submitted

January 25, 2017

First Posted

January 30, 2017

Study Start

July 1, 2016

Primary Completion (Estimated)

July 1, 2036

Study Completion (Estimated)

July 1, 2036

Last Updated

March 13, 2024

Record last verified: 2024-03

Locations